Learning is life

As of January 2026, the Indian pharma sector faces a massive bottleneck: over 13,000 plants require inspection, yet only ~1,100 field inspectors are active. While the government has enforced Revised Schedule M, Laghu Udhyog Bharti is pushing for a vital extension until December 2026 to prevent the closure of thousands of MSMEs and ensure the continued supply of affordable medicine.

Improving productivity & quality is critical to ensuring efficient operations, regulatory compliance & the delivery of high-quality products

Draft guidance for industry entitled “Dosage and Administration Section of Labeling for Human Prescription Drug and Biological Products

Pastes are intended for application to the skin, oral cavity, or mucous membranes.

WHO Expert Committee on Specifications for Pharmaceutical Preparations has published the Technical Report Series TRS 1044 2022 56th Report